Opiant Pharmaceuticals, Inc. announced the appointment of Richard J. Daly as a non-executive director and a member of the Audit Committee. Mr. Daly has supported the successful launch of ten drugs during a twenty seven year career in the biotech and pharmaceutical industry. With his appointment, the Opiant Board now consists of six members, four of whom are independent. Mr. Daly is currently the Chairman and Chief Executive Officer of Neuralstem, Inc. Mr. Daly is currently a member of the Board of Directors of Catalyst Pharmaceuticals.